Clinical Trial Update: Safety and Immunogenicity of a Zoster Vaccine in SLE [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and immunogenicity of a zoster vaccine in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Zoster vaccine (varicella-zoster vaccine)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED